List of Tables
Table 1. Respiratory Distress Syndrome Market Trends
Table 2. Respiratory Distress Syndrome Market Drivers & Opportunity
Table 3. Respiratory Distress Syndrome Market Challenges
Table 4. Respiratory Distress Syndrome Market Restraints
Table 5. Global Respiratory Distress Syndrome Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Respiratory Distress Syndrome Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Respiratory Distress Syndrome Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Respiratory Distress Syndrome Product Type
Table 9. Key Companies Time to Begin Mass Production of Respiratory Distress Syndrome
Table 10. Global Respiratory Distress Syndrome Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Distress Syndrome as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Respiratory Distress Syndrome Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Respiratory Distress Syndrome Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Respiratory Distress Syndrome Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Respiratory Distress Syndrome Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Respiratory Distress Syndrome Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Respiratory Distress Syndrome Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Respiratory Distress Syndrome Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Respiratory Distress Syndrome Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Respiratory Distress Syndrome Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Respiratory Distress Syndrome Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Respiratory Distress Syndrome Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Respiratory Distress Syndrome Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Respiratory Distress Syndrome Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Respiratory Distress Syndrome Sales Value by Region (2019-2024) & (%)
Table 27. Global Respiratory Distress Syndrome Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Respiratory Distress Syndrome Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Respiratory Distress Syndrome Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Respiratory Distress Syndrome Sales Value, (2025-2030) & (US$ Million)
Table 31. Chiesi Farmaceutici Basic Information List
Table 32. Chiesi Farmaceutici Description and Business Overview
Table 33. Chiesi Farmaceutici Respiratory Distress Syndrome Products, Services and Solutions
Table 34. Revenue (US$ Million) in Respiratory Distress Syndrome Business of Chiesi Farmaceutici (2019-2024)
Table 35. Chiesi Farmaceutici Recent Developments
Table 36. CR-Double Crane Basic Information List
Table 37. CR-Double Crane Description and Business Overview
Table 38. CR-Double Crane Respiratory Distress Syndrome Products, Services and Solutions
Table 39. Revenue (US$ Million) in Respiratory Distress Syndrome Business of CR-Double Crane (2019-2024)
Table 40. CR-Double Crane Recent Developments
Table 41. ONY Biotech Basic Information List
Table 42. ONY Biotech Description and Business Overview
Table 43. ONY Biotech Respiratory Distress Syndrome Products, Services and Solutions
Table 44. Revenue (US$ Million) in Respiratory Distress Syndrome Business of ONY Biotech (2019-2024)
Table 45. ONY Biotech Recent Developments
Table 46. AbbVie Basic Information List
Table 47. AbbVie Description and Business Overview
Table 48. AbbVie Respiratory Distress Syndrome Products, Services and Solutions
Table 49. Revenue (US$ Million) in Respiratory Distress Syndrome Business of AbbVie (2019-2024)
Table 50. AbbVie Recent Developments
Table 51. Yuhan Corporation Basic Information List
Table 52. Yuhan Corporation Description and Business Overview
Table 53. Yuhan Corporation Respiratory Distress Syndrome Products, Services and Solutions
Table 54. Revenue (US$ Million) in Respiratory Distress Syndrome Business of Yuhan Corporation (2019-2024)
Table 55. Yuhan Corporation Recent Developments
Table 56. JW Pharmaceuticals Basic Information List
Table 57. JW Pharmaceuticals Description and Business Overview
Table 58. JW Pharmaceuticals Respiratory Distress Syndrome Products, Services and Solutions
Table 59. Revenue (US$ Million) in Respiratory Distress Syndrome Business of JW Pharmaceuticals (2019-2024)
Table 60. JW Pharmaceuticals Recent Developments
Table 61. Noargen Basic Information List
Table 62. Noargen Description and Business Overview
Table 63. Noargen Respiratory Distress Syndrome Products, Services and Solutions
Table 64. Revenue (US$ Million) in Respiratory Distress Syndrome Business of Noargen (2019-2024)
Table 65. Noargen Recent Developments
Table 66. Key Raw Materials Lists
Table 67. Raw Materials Key Suppliers Lists
Table 68. Respiratory Distress Syndrome Downstream Customers
Table 69. Respiratory Distress Syndrome Distributors List
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
Table 73. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Respiratory Distress Syndrome Product Picture
Figure 2. Global Respiratory Distress Syndrome Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Respiratory Distress Syndrome Sales Value (2019-2030) & (US$ Million)
Figure 4. Respiratory Distress Syndrome Report Years Considered
Figure 5. Global Respiratory Distress Syndrome Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Respiratory Distress Syndrome Revenue in 2023
Figure 7. Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Poractant Alfa Picture
Figure 9. Beractant Picture
Figure 10. Calfactant Picture
Figure 11. Others Picture
Figure 12. Global Respiratory Distress Syndrome Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Respiratory Distress Syndrome Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Very Preterm Infants
Figure 15. Product Picture of Moderate to Late Preterm Infants
Figure 16. Product Picture of Others
Figure 17. Global Respiratory Distress Syndrome Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Respiratory Distress Syndrome Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Respiratory Distress Syndrome Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Respiratory Distress Syndrome Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Respiratory Distress Syndrome Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Respiratory Distress Syndrome Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Respiratory Distress Syndrome Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Respiratory Distress Syndrome Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Respiratory Distress Syndrome Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Respiratory Distress Syndrome Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Respiratory Distress Syndrome Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Respiratory Distress Syndrome Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Respiratory Distress Syndrome Sales Value (%), (2019-2030)
Figure 30. United States Respiratory Distress Syndrome Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Respiratory Distress Syndrome Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Respiratory Distress Syndrome Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Respiratory Distress Syndrome Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Respiratory Distress Syndrome Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Respiratory Distress Syndrome Sales Value by Application (%), 2023 VS 2030
Figure 36. China Respiratory Distress Syndrome Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Respiratory Distress Syndrome Sales Value by Type (%), 2023 VS 2030
Figure 38. China Respiratory Distress Syndrome Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Respiratory Distress Syndrome Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Respiratory Distress Syndrome Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Respiratory Distress Syndrome Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Respiratory Distress Syndrome Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Respiratory Distress Syndrome Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Respiratory Distress Syndrome Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Respiratory Distress Syndrome Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Respiratory Distress Syndrome Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Respiratory Distress Syndrome Sales Value by Application (%), 2023 VS 2030
Figure 48. India Respiratory Distress Syndrome Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Respiratory Distress Syndrome Sales Value by Type (%), 2023 VS 2030
Figure 50. India Respiratory Distress Syndrome Sales Value by Application (%), 2023 VS 2030
Figure 51. Respiratory Distress Syndrome Industrial Chain
Figure 52. Respiratory Distress Syndrome Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
